Navigation Links
Pain from the brain
Date:2/24/2013

activity of the leg muscles was measured at the same time to determine which muscles were engaged during the scans.

The researchers found that the brain function of individuals with the psychogenic illness was not normal. The changes were, however, very different from the brains of individuals with the organic (genetic) disease.

Dr Anette Schrag, from UCL, said: "Finding abnormalities of brain function that are very different from those in the organic form of dystonia opens up a way for researchers to learn how psychological factors can, by changing brain function, lead to physical problems."

Dr Rowe added: "What struck me was just how very different the abnormal brain function was in patients with the genetic and the psychogenic dystonia. Even more striking was that the differences were there all the time, whether the patients were resting or trying to move."

Additionally, the researchers found that one part of the brain previously thought to indicate psychogenic disease is unreliable: abnormal activity of the prefrontal cortex was thought to be the hallmark of psychogenic diseases. In this study, the scientists showed that this abnormality is not unique to psychogenic disease, since activity was also present in the patients with the genetic cause of dystonia when they tried to move their foot.

Dr Arpan Mehta, from the University of Cambridge, said: "It is interesting that, despite the differences, both types of patient had one thing in common - a problem at the front of the brain. This area controls attention to our movements and although the abnormality is not unique to psychogenic dystonia, it is part of the problem."

This type of illness is very common. Dr Schrag said: "One in six patients that see a neurologist has a psychogenic illness. They are as ill as someone with organic disease, but with a different cause and different treatment needs. Understanding these disorders, diagnosing them early and fi
'/>"/>

Contact: Genevieve Maul
gm349@admin.cam.ac.uk
44-012-237-65542
University of Cambridge
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. WUSTL researcher gets $2.25 million grant to better understand traumatic brain injury
2. Has evolution given humans unique brain structures?
3. Case Western Reserve University joins BrainGate clinical trial
4. Rutgers neuroscientist sheds light on cause for chemo brain
5. FDA Panel to Consider Brain Stimulator for Epilepsy
6. Brains of Fetuses Build a Bridge Between Regions, Images Show
7. Children with brain lesions able to use gestures important to language learning
8. First signals from brain nerve cells with ultrathin nanowires
9. Momentum builds in quest to find cure for childhood brain disease
10. Fluorescent Tracer Lights Up Brain Tumor for Surgery
11. Damage to Tiny Blood Vessels in Brain May Raise Alzheimers Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... Phoenix, AZ (PRWEB) December 25, 2014 ... comes to outstanding customer service and affordable quality regarding ... metropolitan area announces recognition in 2014 by the “Queen ... and Sons has earned an impressive reputation over the ... pricing on a wide range of contractor services for ...
(Date:12/24/2014)... Over 700 toys, that’s what AlignLife ... 700 smiling little faces this holiday that might not ... monetary donations was given to the various charities as ... incur through the year. Some of the charities chosen ... , Shrine's Children's Hospitals, Toys for Tots and Crisis ...
(Date:12/24/2014)... Connie Casad, MD, a well-known and respected gynecologist, ... years of practice experience in Dallas, Texas, has announced ... dietary detoxification. The second study is scheduled to begin ... test patients who just completed a 21-day detoxification regimen. ... conducting the study, Dr. Casad said, "About 10 years ...
(Date:12/24/2014)... 2014 Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) ... litigation currently underway in Pennsylvania’s Philadelphia Court of Common ... 24, 2014, court documents indicate that 1,183 claims had ... who developed gynecomastia (male breast growth) and other complications ... indicates that this represents an increase of more than ...
(Date:12/24/2014)... 2014 Dr. Vu Ho, a Dallas ... his practice and med-spa with the addition of new ... of cosmetic treatments and services. , “Silk Peel is ... says Dr. Ho. “As a result it can address ... sun spots, discolorations or blemishes.” , Similar to microdermabrasion, ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 2Health News:Parker & Sons Announces Recognition In 2014 By The “Queen Of Clean” For Impressive Contractor Services In Arizona 3Health News:AlignLife Donates Over 700 Toys This Year 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2
... when malignancy is found early , , FRIDAY, Feb. ... Bader Ginsburg will face tough challenges following her surgery ... , At this point, it,s not clear exactly what ... suggest pancreatic adenocarcinoma, which accounts for about 85 percent ...
... Is No Champion of Corporate Governance,TUCSON, Ariz., Feb. 6 ... ) today commented on the recent announcement that an ... CITY) together with other related persons, including Donald E. ... Avalon, intends to initiate a consent solicitation against the ...
... PARK, Calif., Feb. 6 ROXRO announced today ... accepted for review the New Drug,Application (NDA) for ... management of acute moderate to severe pain.,ROX-888 is ... (NSAID), designed to provide ambulatory patients with a,convenient, ...
... Nu Skin Enterprises, Inc. (NYSE: NUS ) today announced ... quarterly cash dividend to $0.115 per share. Annually, this would ... The increase begins in the first quarter and will be ... 27, 2009. "Because of our financial stability and strong cash flow, ...
... 35% over same period in Fiscal 2008 -, ... dollars unless otherwise noted),BELLEVILLE, ON, Feb. 6 /PRNewswire-FirstCall/ ... research-based, technology-driven Canadian biopharmaceutical company, today announced financial ... fiscal year, ending December 31, 2008. , "We ...
... students with an in-depth licensed practical nursing career resource center to ... today,s thriving nursing industry. , ... Seattle, Washington (PRWEB) ... Nursing Career Resource Center offers comprehensive career and education information ...
Cached Medicine News:Health News:Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer 2Health News:Supreme Court Justice Ginsburg Faces Tough Battle Against Pancreatic Cancer 3Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 2Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 3Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 4Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 5Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 6Health News:Providence Service Corporation Comments on Consent Solicitation by Avalon Correctional Services, Inc. 7Health News:ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain 2Health News:ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain 3Health News:Nu Skin Enterprises Announces 5 Percent Increase in Quarterly Dividend 2Health News:Bioniche Reports Fiscal 2009 Second Quarter 2Health News:Bioniche Reports Fiscal 2009 Second Quarter 3Health News:Bioniche Reports Fiscal 2009 Second Quarter 4Health News:Bioniche Reports Fiscal 2009 Second Quarter 5Health News:Bioniche Reports Fiscal 2009 Second Quarter 6Health News:Bioniche Reports Fiscal 2009 Second Quarter 7Health News:Bioniche Reports Fiscal 2009 Second Quarter 8Health News:Bioniche Reports Fiscal 2009 Second Quarter 9Health News:Licensed Practical Nurse Career Resource Center Launches 2Health News:Licensed Practical Nurse Career Resource Center Launches 3
(Date:12/24/2014)... 24, 2014  Actavis plc (NYSE: ... received a complete response letter from the U.S. ... Drug Application (NDA) for the fixed-dose combination (FDC) ... hypertension.   Photo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO ... the receipt of a complete response letter, Actavis ...
(Date:12/24/2014)... /PRNewswire/  -- Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the patented biopharmaceutical, modernized traditional Chinese medicine ... released unaudited preliminary financial results for the first ... Year 2015 Ended September 30, 2014 Financial Highlights: ... $14.7 million in 1Q14 with gross margins improved ...
(Date:12/24/2014)... Dec. 24, 2014 Soligenix, Inc. (OTCQB: ... company developing products that address unmet medical needs ... announced today that on December 24, 2014 it ... The Company raised approximately $2.3 million in ... use the net proceeds from the offering to ...
Breaking Medicine Technology:Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 2Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 3Actavis Confirms Complete Response Letter for Nebivolol/Valsartan Fixed-Dose Combination for Hypertension 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 2TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 3TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 4TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 5TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 6TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 7TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 8TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 9TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 10TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 11TPI Presents Unaudited Preliminary First Quarter Fiscal Year 2015 Financial Results 12Soligenix Announces Closing of Public Offering of Units 2Soligenix Announces Closing of Public Offering of Units 3
... Jan. 10, 2011 Ascension Orthopedics, Inc., a market ... a European patent for a PyroCarbon humeral head design ... Modular Shoulder System released in September 2010. ... of Ascension Orthopedics, commented, "I am very pleased our ...
... Inc. (Nasdaq: RDEA ) today announced that ... Bayer HealthCare AG (Bayer) under the terms of their ... Ardea,s mitogen-activated ERK kinase (MEK) inhibitor compounds for cancer ... initiation of a Phase 2 clinical study evaluating BAY ...
Cached Medicine Technology:Ascension Orthopedics Granted Patent for PyroCarbon Humeral Head Design 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 2Ardea Biosciences Earns $15 Million Payment from Bayer HealthCare AG for Achievement of Important Clinical Milestone in Ongoing Collaboration 3
... Managing diabetes requires making decisions about insulin ... exercise. These decisions are guided by data ... information, and by the patterns that can ... Care Providers when the data is presented ...
... The Worlds First Solid-State Three-Color ... chosen to purchase over 3,000 Lumenis ... a busy practice, the Novus Varia ... lasers into a single, compact system ...
... Solid-State Three-Color Photocoagulator.,Retinal physicians throughout the ... 3,000 Lumenis multi-color photocoagulators.,For the retinal ... Novus Varia integrates green, yellow, and ... compact system that supports your treatment ...
The ring maintains the bag tension avoiding the development of posterior capsule pleats. It is also established to compensate the efforts induced during the bag retraction....
Medicine Products: